First dementia treatment drug approved for Australia, supported by NIF capacity Posted on June 16, 2025June 16, 2025 by Sarah Cole
Network models brain changes in motor neurone disease to develop imaging tools for clinicians Posted on May 28, 2025May 29, 2025 by Sarah Cole
New molecular-imaging network launched to benefit cancer, dementia imaging and new radiopharmaceuticals Posted on May 26, 2025 by Sarah Cole
Advance Queensland: AI-powered software to optimise brain stimulation therapy for major depression Posted on February 18, 2025April 7, 2025 by aburton
AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing Posted on February 3, 2025February 6, 2025 by aburton
A joint effort: machine learning’s search for the first MRI-based biomarker of osteoarthritis Posted on December 9, 2024December 14, 2024 by aburton
Advancing the fight against motor neurone disease Posted on November 15, 2024February 6, 2025 by aburton
Transforming melanoma diagnosis: the power of 3D whole-body imaging for early detection Posted on September 5, 2024September 5, 2024 by aburton
Amazon: Empowering epilepsy patients to live fully with AWS Cloud Posted on August 25, 2024September 25, 2024 by aburton
AI tool to personalise brain stimulation therapy for major depression Posted on August 21, 2024December 16, 2024 by aburton
